COSCIENS Biopharma Inc.
CSCIF
$4.98
-$0.32-6.04%
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 5.28M | 5.01M | 7.31M | 8.52M | 9.33M |
| Total Receivables | 2.37M | 1.99M | 1.26M | 1.61M | 2.78M |
| Inventory | 960.00K | 1.10M | 1.31M | 1.76M | 1.82M |
| Prepaid Expenses | 1.02M | 1.19M | 2.99M | 1.38M | 1.91M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 66.00K | 108.00K | 259.00K | 570.00K | 657.00K |
| Total Current Assets | 9.69M | 9.39M | 11.50M | 13.84M | 16.50M |
|
|
|||||
| Total Current Assets | 9.69M | 9.39M | 11.50M | 13.84M | 16.50M |
| Net Property, Plant & Equipment | 8.75M | 9.24M | 9.81M | 9.89M | 10.92M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 2.00K | 2.00K | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 206.00K | 202.00K | 125.00K | 132.00K | 132.00K |
| Total Assets | 18.85M | 18.84M | 21.43M | 23.86M | 27.56M |
|
|
|||||
| Total Accounts Payable | 536.00K | 594.00K | 745.00K | 1.03M | 1.54M |
| Total Accrued Expenses | 265.00K | 332.00K | 1.14M | 923.00K | 1.53M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 187.00K | 186.00K | 215.00K | 212.00K | 209.00K |
| Total Finance Division Other Current Liabilities | 1.25M | 573.00K | 4.91M | 1.82M | 2.30M |
| Total Other Current Liabilities | 1.25M | 573.00K | 4.91M | 1.82M | 2.30M |
| Total Current Liabilities | 2.24M | 1.69M | 3.61M | 3.98M | 5.58M |
|
|
|||||
| Total Current Liabilities | 2.24M | 1.69M | 3.61M | 3.98M | 5.58M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 1.77M | 1.84M | 1.93M | 1.96M | 2.05M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | 12.04M | 12.84M | 12.83M |
| Total Liabilities | 4.01M | 3.52M | 17.59M | 18.78M | 20.46M |
|
|
|||||
| Common Stock & APIC | 22.63M | 22.63M | 22.62M | 22.62M | 22.60M |
| Retained Earnings | -9.95M | -9.75M | -20.51M | -19.05M | -17.23M |
| Treasury Stock & Other | 2.17M | 2.45M | 1.73M | 1.51M | 1.72M |
| Total Common Equity | 14.84M | 15.32M | 3.84M | 5.08M | 7.10M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 14.84M | 15.32M | 3.84M | 5.08M | 7.10M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 14.84M | 15.32M | 3.84M | 5.08M | 7.10M |
|
|
|||||